PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 28, 2026Kidney International Reports0 citationsOpen Access

Wcn26-8089 Efficacy and Safety of Telitacicept in Primary Immunoglobulin a Nephropathy Patients With Severely Impaired Renal Function

YYYanrong YangZSZiyan ShenHZHan Zhang

Key Points

  • The central aim is to evaluate the efficacy and safety of telitacicept in patients suffering from primary immunoglobulin A nephropathy with severely impaired renal function.
  • Clinical correlation with systemic sclerosis evaluated
  • Exclusion of other thrombotic microangiopathies
  • Histological confirmation via renal biopsy when feasible
  • Early initiation of ACE inhibitors such as captopril for improving survival
  • Timely diagnosis of renal complications is crucial
  • ACE inhibitors improve short-term survival
  • There is a need for predictive biomarkers and better therapeutic strategies

Abstract

Conclusion: Scleroderma renal crisis (SRC) is a rare complication of systemic sclerosis, more frequent in the diffuse form, which can rapidly progress to acute kidney injury, need for renal replacement therapy, and death.Timely diagnosis requires clinical correlation with systemic sclerosis, exclusion of other thrombotic microangiopathies, and, when feasible, histological confirmation via renal biopsy.Early initiation of ACE inhibitors, particularly captopril, improves shortterm survival but does not guarantee renal recovery in all cases, highlighting the clinical heterogeneity and the need for predictive biomarkers and more effective therapeutic strategies.I have no potential conflict of interest to disclose.I did not use generative AI and AI-assisted technologies in the writing process.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Yang et al. (2026) studied this question.

synapsesocial.com/papers/69c770888bbfbc51511e0a53https://doi.org/10.1016/j.ekir.2026.106308
Ask AI
Helpful
Bookmark
Share
View Full Paper